To link your Twitter account with your DLD profile, we need you to enter your DLD Email and Password. You only do this once.
To link your Facebook account with your DLD profile, we need you to enter your DLD Email and Password. You only do this once.
Dr. Beatrix Foerster is founder of the biotech company PYCAB, that is developing novel antibody drugs for the treatment of antibiotic resistent bacteria. After graduating from the university of Marburg she did her PhD at the Max-Planck Institute of Biochemistry with Axel Ullrich who has developed several blockbuster drugs such as Herceptin for breast cancer treatment After contributing to the founding of Suppremol, a biotech company developing drugs for autoimmune diseases, she moved to Stanford University to do research in the field of allergy and asthma. In addition, she worked as a consultant for the Industrial Investment Council in San Francisco and was a guest auditor at Stanford School of Business. After her return to Germany she was head of a laboratory developing novel anti-cancer drugs at TRION Research GmbH. Prior to starting her own business she worked as a project manager for clinical and translational projects at the Helmholtz Zentrum München.